HAVCR2 and neoplasm: This underscores a complex and dynamic immunological landscape, wherein TIM-3 and Gal-9 may act as central mediators of immune suppression while simultaneously shaping the chemokines’ expression in a manner that favors tumor progression and immune system modulation.